Matterport (NASDAQ: MTTR) bears are out in full force this year as shares of the spatial data company that maps spaces in three-dimensional (3D) formats and makes digital twins have fallen a whopping 80% so far in 2022. Matterport had spiked handsomely last year after it made its stock market debut via the special purpose acquisition company (SPAC) route. Let's look at the reasons why the market has turned bearish on Matterport stock. Read More...
Motley Fool
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
With the market down by more than 21% in 2022, we’re officially in a bear market, and many investors are scrambling to protect themselves. AbbVie’s (NYSE: ABBV) stock is up 9.9% this year, and with a bunch of recently reported clinical trial results and green lights from regulators, it isn’t too surprising why. Most recently, on Sept. 10, it announced that a pair of its phase 3 trials of Skyrizi, a psoriatic arthritis drug that’s already on the market, showed that the drug was performing favorably in long-term followup studies.
